+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lesinurad"

Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Lesinurad is a drug used to treat hyperuricemia, a condition in which the body produces too much uric acid. It is used in combination with xanthine oxidase inhibitors (XOIs) to reduce the levels of uric acid in the blood. Lesinurad is approved for use in the United States, Europe, and other countries. It is used to treat gout, a type of immune disorder caused by the buildup of uric acid crystals in the joints. Lesinurad works by blocking the reabsorption of uric acid in the kidneys, allowing it to be excreted in the urine. This helps reduce the levels of uric acid in the blood and reduce the risk of gout flares. Lesinurad is a relatively new drug in the immune disorders drugs market. It is used in combination with XOIs to treat hyperuricemia and gout. Lesinurad is approved for use in the United States, Europe, and other countries. Companies in the Lesinurad market include AstraZeneca, Ardea Biosciences, and Ironwood Pharmaceuticals. Show Less Read more